Review of Drug Master Files in Advance of Certain ANDA Submissions Under GDUFA
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 17, 2024
October 17, 2024
bd04aec8-c53e-4d1d-b770-a5c8267fed47
Related Documents
Requests for Reconsideration at the Division Level Under GDUFA
Guidance DocumentOctober 16, 2024Center for Drug Evaluation and Research
Product-Specific Guidance Meetings Between FDA and ANDA Applicants Under GDUFA: Guidance for Industry
Guidance DocumentAugust 20, 2024Center for Drug Evaluation and Research
Providing Over-the-Counter Monograph Submissions in Electronic Format
Guidance DocumentJuly 25, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox